Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06770049 · ClinicalTrials.gov registry record · Phase 4
Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized Trial
A Phase 4 study of Obesity, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 228
- Enrollment target
- 1
- Study location
NCT06770049 is a Phase 4 study of Obesity that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 228 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06770049, a Phase 4 study of Obesity, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 228 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop an evidence-based precision medicine approach for obesity that enhances weight loss and promotes weight loss maintenance.
Conditions Studied
Interventions
- BEHAVIORAL Standard Lifestyle Intervention (SLI) program
- BEHAVIORAL Phenotype-tailored Lifestyle Intervention (PLI) program
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2025-01-22 |
| Est. Completion | 2030-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06770049
The ClinicalTrials.gov registry entry for NCT06770049 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 228 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (72% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Standard Lifestyle Intervention (SLI) program is the first listed.
NCT06770049 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06770049 about?
NCT06770049 is a clinical study titled "Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized Trial". The purpose of this study is to develop an evidence-based precision medicine approach for obesity that enhances weight loss and promotes weight loss maintenance.
What is the current status of trial NCT06770049?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 228 participants. The study started on 2025-01-22. Estimated completion is 2030-12.
What conditions does trial NCT06770049 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT06770049?
The interventions under investigation include: Standard Lifestyle Intervention (SLI) program (BEHAVIORAL), Phenotype-tailored Lifestyle Intervention (PLI) program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06770049?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06770049 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics
RECRUITING · Phase 4
-
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
RECRUITING · Phase 4
-
Weight Loss Study: Genetics and Response to Naltrexone/Bupropion
RECRUITING · Phase 4
-
Fibrosis Lessens After Metabolic Surgery
RECRUITING · Phase 4
-
Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
RECRUITING · Phase 4
-
A Study of a Novel Precision Medicine Approach For Obesity
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.